Stock-split proposal powers Emco &bliss gvs

Emco surged 6.18% Rs 1529 at 10:05 IST on BSE, after the company said its board will consider stock split at a meeting to be held on 17 January 2008.

The company made this announcement after trading hours on Tuesday, 8 January 2008.

Meanwhile, BSE Sensex was down 12.66 points to 20,860.67.

On BSE, 508 shares were traded in the counter. The stock had an average daily volume of 15,509 shares in the past one quarter.

The stock hit a high of Rs 1565 and a low of Rs 1460 so far during the day. The stock hit a 52-week high of Rs 1629 on 31 December 2007 and a 52-week low of Rs 712.05 on 11 January 2007.

The mid-cap scrip had outperformed the market over the past one month till 7 January 2008, gaining 7.48% as compared to the Sensex's return of 4.24%. It had also outperformed the market in the past one quarter, rising 27.21% as compared to the Sensex's rise of 13.85%.

The company's current equity is Rs 10.54. Face value per share is Rs 10.

The current price of Rs 1529 discounts Q2 September 2007 annualized EPS of Rs 40.59 by a PE multiple of 37.67.

Emco's net profit rose 19.4% to Rs 10.36 crore on 41.1% growth in sales to Rs 184.17 crore in Q2 September 2007 over Q2 September 2006.

The company is engaged in manufacturing and marketing furnace and rectifier transformers and electronic energy meters.

 

Bliss GVS Pharma gains on stock split proposal

Bliss GVS Pharma gained 2.39% to Rs 620.25 at 10:44 IST on BSE, after the company said its board will consider stock split at a meeting to be held on 18 January 2008.

The company made this announcement after trading hours on Tuesday, 8 January 2008.

Meanwhile, BSE Sensex was down 98.25 points or 0.47% to 20,775.08.

On BSE, 3,141 shares were traded in the counter. The stock had an average daily volume of 4,700 shares in the past one quarter.

The stock hit a high of Rs 636 so far during the day, which is a record high. The stock touched a low of Rs 610 so far during the day. The stock hit a 52-week low of Rs 41.05 on 5 March 2007.

The small-cap scrip had outperformed the market over the past one month till 7 January 2008, gaining 28.46% as compared to the Sensex's return of 4.24%. It had also outperformed the market in the past one quarter, rising 85.13% as compared to the Sensex's rise of 13.85%.

The company's current equity is Rs 6.31. Face value per share is Rs 10.

The current price of Rs 620.25 discounts Q2 September 2007 annualized EPS of Rs 77.46 by a PE multiple of 8.01.

On 13 November 2007, Bliss GVS Pharma bagged an order worth Rs 25 crore for supplying anti-malarial drugs to African countries.

Bliss GVS Pharma's net profit surged 4788% to Rs 12.22 crore on 1894% growth in sales to Rs 29.91 crore in Q2 September 2007 over Q2 September 2006.

The company manufactures and distributes soft vaginal pessaries and anal suppositories. It operates in two segments, health care products and pharma products